Physician

Irfan Raheem, M.D.

According to 2025 Medicare claims, Irfan Raheem, M.D. (NPI: 1831486190) practices rheumatology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES LLC (NPI: 1598205072; TIN: 831053374) and primary practice location at 33324-1855.

Raheem's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 692 traditional Medicare patients, billed 68,110 HCPCS/CPT codes, and received $1,822,509 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,460 prescription claims across 564 beneficiaries totaling $1,520,053 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 74 records totaling $1,690. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $59,724 to $1,822,509. Similarly, Part D prescription costs have risen steadily, from $59,746 to $1,520,053. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$927K$1.9M2016 Medicare payment: $59,724 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $473,598 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $648,504 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $548,488 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $740,900 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,337,303 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,195,137 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,853,061 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,822,509 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20162622,523$59,724
201770532,566$473,598
201874349,809$648,504
201968922,423$548,488
202064344,901$740,900
202162088,095$1,337,303
202265085,416$1,195,137
202370276,701$1,853,061
202469268,110$1,822,509

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$760K$1.5M2015 Drug cost: $59,746 (USD; Tot_Drug_Cst)2016 Drug cost: $155,848 (USD; Tot_Drug_Cst)2017 Drug cost: $306,788 (USD; Tot_Drug_Cst)2018 Drug cost: $590,125 (USD; Tot_Drug_Cst)2019 Drug cost: $876,442 (USD; Tot_Drug_Cst)2020 Drug cost: $1,112,517 (USD; Tot_Drug_Cst)2021 Drug cost: $1,174,571 (USD; Tot_Drug_Cst)2022 Drug cost: $1,225,890 (USD; Tot_Drug_Cst)2023 Drug cost: $1,361,715 (USD; Tot_Drug_Cst)2024 Drug cost: $1,520,053 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015114408$59,746
2016180658$155,848
20172731,096$306,788
20183051,155$590,125
20194301,523$876,442
20204392,006$1,112,517
20214832,077$1,174,571
20225412,392$1,225,890
20235652,505$1,361,715
20245642,460$1,520,053

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6341,308$102
96401Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle167356$58
76942Ultrasonic guidance for needle placement152225$45
J0897Injection, denosumab, 1 mg15814,760$20
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg2312,601$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab341,072$315,217
Enbrel SureclickEtanercept19756$214,571
ProliaDenosumab10618,720$189,622
Cimzia (2 Pack)Certolizumab Pegol23644$152,862
RinvoqUpadacitinib19570$138,644

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.74$1,690Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Irfan Raheem, M.D.?

Tedicare shows public-source Medicare data for Irfan Raheem, M.D. (NPI 1831486190), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Irfan Raheem, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Irfan Raheem, M.D.?

Irfan Raheem, M.D. is linked to AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES LLC (billing NPI 1598205072) in the available physician profile data.

Does Irfan Raheem, M.D. have Open Payments data?

Irfan Raheem, M.D. has 74 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.